Articles related to ANTIDEPRESSANTS

Rapid-acting antidepressants represent a pivotal development in depression treatment, targeting the glutamatergic system for quicker and more comprehensive symptom relief.

Escitalopram shows promising results in the acute phase treatment of major depressive disorder, offering a potentially more effective and tolerable option for patients compared to other SSRIs and newer antidepressants.

Groundbreaking research reveals ketamine’s potential as an effective alternative to ECT in treating treatment-resistant depression, offering new hope to millions.

The advent of zuranolone may be going beyond postpartum depression, with 87.5% of patients noticing improvements within the first week of treatment for MDD.

Recent findings indicate a significant association between SSRI use in children and delayed puberty, with an odds ratio of 1.44. This underscores the importance of considering potential developmental impacts when prescribing these medications.

With more than 5,000 patients studied in clinical trials, Exxua has demonstrated effectiveness for relieving depressive symptoms with an acceptable side effect profile.